IMPACT OF THE PEGYLATED-INTERFERON AND RIBAVIRIN THERAPY ON THE TREATMENT-RELATED MORTALITY OF PATIENTS WITH CIRRHOSIS DUE TO HEPATITIS C VIRUS

by Kelly Fernanda Nomura DRESCH, Angelo Alves de MATTOS, Cristiane Valle TOVO, Fernanda Quadros de ONOFRIO, Leandro CASAGRANDE, Alberi Adolfo FELTRIN, Iago Christofoli de BARROS, Paulo Roberto Lerias de ALMEIDA
Published 2016-01-01